|
Market Closed -
Bombay S.E.
10:02:29 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 30.00 INR | -2.76% |
|
-6.25% | -28.74% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 91.84 | 79.88 |
| Change | - | -13.02% |
| Enterprise Value (EV) 1 | 61.1 | 64.14 |
| Change | - | 4.98% |
| P/E | 21.2x | 19.1x |
| PBR | 1.04x | 0.86x |
| PEG | -1.1x | -5.48x |
| Capitalization / Revenue | 1.12x | 0.84x |
| EV / Revenue | 0.74x | 0.68x |
| EV / EBITDA | 7.34x | 6.31x |
| EV / EBIT | 16x | 12.6x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 1.896 | 1.83 |
| Distribution rate | - | - |
| Net sales 1 | 82.35 | 94.91 |
| EBITDA 1 | 8.319 | 10.16 |
| EBIT 1 | 3.821 | 5.079 |
| Net income 1 | 3.947 | 4.179 |
| Net Debt 1 | -30.75 | -15.75 |
| Reference price 2 | 40.24 | 35.00 |
| Nbr of stocks (in thousands) | 2,282 | 2,282 |
| Announcement Date | 26/08/25 | 22/08/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 739K | |
| 13.14x | 0.4x | 8.38x | 2.94% | 116B | |
| 15.8x | 1.95x | 9.7x | 0.65% | 104B | |
| -303.77x | 21.22x | -358.78x | -.--% | 62.85B | |
| 27.2x | 2.37x | 13.44x | 0.79% | 29.89B | |
| 14.24x | 1.55x | 9.39x | 2.48% | 29.55B | |
| 24.5x | 2.72x | 13.79x | 1.31% | 27.83B | |
| 8.22x | 1.46x | 6.64x | -.--% | 21.79B | |
| 30.62x | 5.47x | 22.33x | 2.28% | 20.66B | |
| 30.69x | 2.86x | 12.88x | 1.46% | 17.09B | |
| Average | -15.48x | 4.44x | -29.14x | 1.32% | 42.87B | |
| Weighted average by Cap. | -29.59x | 4.59x | -43.59x | 1.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
